HomeARTL • NASDAQ
add
Artelo Biosciences Inc
Previous close
$3.90
Day range
$3.75 - $4.05
Year range
$3.15 - $85.80
Market cap
2.66M USD
Avg Volume
20.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.79M | -26.92% |
Net income | -4.17M | -10.27% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 600.00K | -74.34% |
Total assets | 2.80M | -40.38% |
Total liabilities | 4.07M | 121.24% |
Total equity | -1.27M | — |
Shares outstanding | 708.26K | — |
Price to book | -2.06 | — |
Return on assets | -197.09% | — |
Return on capital | 5,102.56% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.17M | -10.27% |
Cash from operations | -2.91M | -13.40% |
Cash from investing | 188.00K | -62.40% |
Cash from financing | 1.61M | 2,719.30% |
Net change in cash | -1.12M | 44.53% |
Free cash flow | -1.91M | -59.34% |
About
Founded
May 2, 2011
Headquarters
Website
Employees
7
